18:09 CET
ESR/EIBALL - Imaging biomarkers and their combinations in the era of artificial intelligence
AI & Machine Learning Hybrid Imaging Imaging Informatics Research
Wednesday, February 27, 08:30 - 10:00
Type of session: Joint Session of the ESR and EIBALL
Topic: AI & Machine Learning, Hybrid Imaging, Imaging Informatics, Research
Moderators: O. Clément (Paris/FR), N. M. deSouza (Sutton/GB)

08:30
Chairpersons' introduction (part 1)
O. Clément; Paris/FR
Learning Objectives

1. To introduce the potential of AI for biomarker selection.
2. To introduce the challenges of managing biomarkers with AI systems.
3. To introduce the speakers.

08:33
Chairpersons' introduction (part 2)
N. M. deSouza; Sutton/GB
Learning Objectives

1. To introduce the potential of AI for biomarker selection.
2. To introduce the challenges of managing biomarkers with AI systems.
3. To introduce the speakers.

08:35
Building and discovering biomarkers with AI
B. Rance; Paris/FR
Learning Objectives

1. To learn about available supervised vs unsupervised machine learning techniques.
2. To learn about deep-learning methods to discover biomarkers.
3. To understand the strength, but also limits and pitfalls, of machine learning methods.

09:00
COST action initiatives as a platform for image biomarker selection
A. Caroli; Ranica/IT
Learning Objectives

1. To learn about how COST actions work and the outputs generated.
2. To appreciate examples of a successful COST action for selecting imaging biomarkers.
3. To understand difficulties in selecting biomarkers for specific indications.

09:25
AI for managing imaging biomarkers: friend or foe?
J. C. Waterton; Manchester/GB
Learning Objectives

1. To learn about multimodality and hybrid imaging biomarkers combinations; are they worthwhile or worthless?
2. To appreciate what genomics has taught us in this area.
3. To understand how we can use AI to manage the imaging biomarker environment.

09:50
Panel discussion: What infrastructure do we need to exploit AI for selecting, validating and managing imaging biomarkers?
This website uses cookies. Learn more